Research Progress on the Mechanism of Ketamine in Neuropathic Pain Comorbid Depression

Qingmei Li,1,* Shuming Liu,2,* Bangyong Qin,3 Xingfeng Liu4,5 1Department of Anesthesiology, The Affiliated Hospital of Zunyi Medical University, Zunyi, 563003, People’s Republic of China; 2Department of Anesthesiology, The Affiliated Stomatological Hospital of Zunyi Medical University, Zunyi, 563003, People’s Republic of China; 3Department of Pain Medicine, The Affiliated Hospital of Zunyi Medical University, Zunyi, 563003, People’s Republic of China; 4Guizhou Key Laboratory of Brain Science, Zunyi Medical University, Zunyi, 563000, People’s Republic of China; 5Guizhou Key Laboratory of Anesthesia and Organ Protection, Zunyi Medical University, Zunyi, 563000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bangyong Qin; Xingfeng Liu, Email [email protected]; [email protected]: This review systematically summarizes the research progress of ketamine and its interaction with specific brain regions in the context of neuropathic pain comorbid with depression. As a non-competitive inhibitor of N-methyl-D-aspartate (NMDA) receptors, Ketamine exerts complex mechanisms and controversial topic. The structure and function of NMDA receptors, as well as the binding sites of ketamine, are summarized, and the hypothesis of disinhibition and neuroplasticity of ketamine’s antidepressant effect is elaborated. The mechanism of key brain regions, such as hippocampus and anterior cingulate cortex, is discussed in detail, and the antidepressant effect of ketamine is explored from the perspective of transcriptomics. Finally, this review integrates bioinformatics, molecular biology and other interdisciplinary approaches to elucidate the therapeutic effects and potential mechanisms of ketamine in treating neuropathic pain and depression comorbidity, providing a comprehensive theoretical basis, new directions for subsequent research and novel insights for the clinical application of ketamine.Keywords: ketamine, neuropathic pain, depression, specific brain regions

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2025-08-09
Primary Topic
Prenatal Screening and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Research Progress on the Mechanism of Ketamine in Neuropathic Pain Comorbid Depression

Dove Medical Press (Taylor and Francis Group)
Prenatal Screening and Diagnostics
article

Research Progress on the Mechanism of Ketamine in Neuropathic Pain Comorbid Depression

article en

Abstract

Qingmei Li,1,* Shuming Liu,2,* Bangyong Qin,3 Xingfeng Liu4,5 1Department of Anesthesiology, The Affiliated Hospital of Zunyi Medical University, Zunyi, 563003, People’s Republic of China; 2Department of Anesthesiology, The Affiliated Stomatological Hospital of Zunyi Medical University, Zunyi, 563003, People’s Republic of China; 3Department of Pain Medicine, The Affiliated Hospital of Zunyi Medical University, Zunyi, 563003, People’s Republic of China; 4Guizhou Key Laboratory of Brain Science, Zunyi Medical University, Zunyi, 563000, People’s Republic of China; 5Guizhou Key Laboratory of Anesthesia and Organ Protection, Zunyi Medical University, Zunyi, 563000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bangyong Qin; Xingfeng Liu, Email [email protected]; [email protected]: This review systematically summarizes the research progress of ketamine and its interaction with specific brain regions in the context of neuropathic pain comorbid with depression. As a non-competitive inhibitor of N-methyl-D-aspartate (NMDA) receptors, Ketamine exerts complex mechanisms and controversial topic. The structure and function of NMDA receptors, as well as the binding sites of ketamine, are summarized, and the hypothesis of disinhibition and neuroplasticity of ketamine’s antidepressant effect is elaborated. The mechanism of key brain regions, such as hippocampus and anterior cingulate cortex, is discussed in detail, and the antidepressant effect of ketamine is explored from the perspective of transcriptomics. Finally, this review integrates bioinformatics, molecular biology and other interdisciplinary approaches to elucidate the therapeutic effects and potential mechanisms of ketamine in treating neuropathic pain and depression comorbidity, providing a comprehensive theoretical basis, new directions for subsequent research and novel insights for the clinical application of ketamine.Keywords: ketamine, neuropathic pain, depression, specific brain regions

Dove Medical Press (Taylor and Francis Group)
National Natural Science Foundation of China
Openalex Percentile: Top 35%
Prenatal Screening and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Research Progress on the Mechanism of Ketamine in Neuropathic Pain Comorbid Depression · Dove Medical Press (Taylor and Francis Group) (2025) | TGRS Research Map | TGRS